Prostate Cancer, Hereditary, 6

Men undergoing ADT displayed a trend toward worsening anxiety as assessed by STAI state scores that did not reach statistical significance, while STAI trait scores showed no change.

Effect: null; 2.34; CI: 95% CI = -0.09 to 4.76

Men undergoing ADT displayed a trend toward worsening anxiety as assessed by STAI state scores that did not reach statistical significance, while STAI trait scores showed no change.

Effect: null; 2.34; CI: 95% CI = -0.09 to 4.76

Men undergoing ADT displayed a trend toward worsening anxiety as assessed by STAI state scores that did not reach statistical significance, while STAI trait scores showed no change.

Effect: null; 2.34; CI: 95% CI = -0.09 to 4.76

Men undergoing ADT displayed a trend toward worsening anxiety as assessed by STAI state scores that did not reach statistical significance, while STAI trait scores showed no change.

Effect: null; 2.34; CI: 95% CI = -0.09 to 4.76

Men undergoing ADT displayed a trend toward worsening anxiety as assessed by STAI state scores that did not reach statistical significance, while STAI trait scores showed no change.

Effect: null; 2.34; CI: 95% CI = -0.09 to 4.76

Men undergoing ADT displayed a trend toward worsening anxiety as assessed by STAI state scores that did not reach statistical significance, while STAI trait scores showed no change.

Effect: null; 2.34; CI: 95% CI = -0.09 to 4.76

Men undergoing ADT displayed a trend toward worsening anxiety as assessed by STAI state scores that did not reach statistical significance, while STAI trait scores showed no change.

Effect: null; 2.34; CI: 95% CI = -0.09 to 4.76

Men undergoing ADT displayed a trend toward worsening anxiety as assessed by STAI state scores that did not reach statistical significance, while STAI trait scores showed no change.

Effect: null; 2.34; CI: 95% CI = -0.09 to 4.76

Men undergoing ADT displayed a trend toward worsening anxiety as assessed by STAI state scores that did not reach statistical significance, while STAI trait scores showed no change.

Effect: null; 2.34; CI: 95% CI = -0.09 to 4.76

Men undergoing ADT displayed a trend toward worsening anxiety as assessed by STAI state scores that did not reach statistical significance, while STAI trait scores showed no change.

Effect: null; 2.34; CI: 95% CI = -0.09 to 4.76

Men undergoing ADT displayed a trend toward worsening anxiety as assessed by STAI state scores that did not reach statistical significance, while STAI trait scores showed no change.

Effect: null; 2.34; CI: 95% CI = -0.09 to 4.76

Men undergoing ADT displayed a trend toward worsening anxiety as assessed by STAI state scores that did not reach statistical significance, while STAI trait scores showed no change.

Effect: null; 2.34; CI: 95% CI = -0.09 to 4.76

Men undergoing ADT displayed a trend toward worsening anxiety as assessed by STAI state scores that did not reach statistical significance, while STAI trait scores showed no change.

Effect: null; 2.34; CI: 95% CI = -0.09 to 4.76

Men undergoing ADT displayed a trend toward worsening anxiety as assessed by STAI state scores that did not reach statistical significance, while STAI trait scores showed no change.

Effect: null; 2.34; CI: 95% CI = -0.09 to 4.76

Men undergoing ADT displayed a trend toward worsening anxiety as assessed by STAI state scores that did not reach statistical significance, while STAI trait scores showed no change.

Effect: null; 2.34; CI: 95% CI = -0.09 to 4.76

Men undergoing ADT displayed a trend toward worsening anxiety as assessed by STAI state scores that did not reach statistical significance, while STAI trait scores showed no change.

Effect: null; 2.34; CI: 95% CI = -0.09 to 4.76

Men undergoing ADT displayed a trend toward worsening anxiety as assessed by STAI state scores that did not reach statistical significance, while STAI trait scores showed no change.

Effect: null; 2.34; CI: 95% CI = -0.09 to 4.76

Men undergoing ADT displayed a trend toward worsening anxiety as assessed by STAI state scores that did not reach statistical significance, while STAI trait scores showed no change.

Effect: null; 2.34; CI: 95% CI = -0.09 to 4.76

Men undergoing ADT displayed a trend toward worsening anxiety as assessed by STAI state scores that did not reach statistical significance, while STAI trait scores showed no change.

Effect: null; 2.34; CI: 95% CI = -0.09 to 4.76

Men undergoing ADT displayed a trend toward worsening anxiety as assessed by STAI state scores that did not reach statistical significance, while STAI trait scores showed no change.

Effect: null; 2.34; CI: 95% CI = -0.09 to 4.76

Men undergoing ADT displayed a trend toward worsening anxiety as assessed by STAI state scores that did not reach statistical significance, while STAI trait scores showed no change.

Effect: null; 2.34; CI: 95% CI = -0.09 to 4.76

Men undergoing ADT displayed a trend toward worsening anxiety as assessed by STAI state scores that did not reach statistical significance, while STAI trait scores showed no change.

Effect: null; 2.34; CI: 95% CI = -0.09 to 4.76

Men undergoing ADT displayed a trend toward worsening anxiety as assessed by STAI state scores that did not reach statistical significance, while STAI trait scores showed no change.

Effect: null; 2.34; CI: 95% CI = -0.09 to 4.76

Men undergoing ADT displayed a trend toward worsening anxiety as assessed by STAI state scores that did not reach statistical significance, while STAI trait scores showed no change.

Effect: null; 2.34; CI: 95% CI = -0.09 to 4.76

Men undergoing ADT displayed a trend toward worsening anxiety as assessed by STAI state scores that did not reach statistical significance, while STAI trait scores showed no change.

Effect: null; 2.34; CI: 95% CI = -0.09 to 4.76

Men undergoing ADT displayed a trend toward worsening anxiety as assessed by STAI state scores that did not reach statistical significance, while STAI trait scores showed no change.

Effect: null; 2.34; CI: 95% CI = -0.09 to 4.76

Men undergoing ADT displayed a trend toward worsening anxiety as assessed by STAI state scores that did not reach statistical significance, while STAI trait scores showed no change.

Effect: null; 2.34; CI: 95% CI = -0.09 to 4.76

Androgen deprivation therapy in men with prostate cancer was associated with statistically significant worsening of depression scores on the PHQ-9 over 6 months compared to eugonadal controls.

Effect: adverse; 0.93; CI: 95%CI= 0.04 to 1.82

Androgen deprivation therapy in men with prostate cancer was associated with statistically significant worsening of depression scores on the PHQ-9 over 6 months compared to eugonadal controls.

Effect: adverse; 0.93; CI: 95%CI= 0.04 to 1.82

Androgen deprivation therapy in men with prostate cancer was associated with statistically significant worsening of depression scores on the PHQ-9 over 6 months compared to eugonadal controls.

Effect: adverse; 0.93; CI: 95%CI= 0.04 to 1.82

Androgen deprivation therapy in men with prostate cancer was associated with statistically significant worsening of depression scores on the PHQ-9 over 6 months compared to eugonadal controls.

Effect: adverse; 0.93; CI: 95%CI= 0.04 to 1.82

Androgen deprivation therapy in men with prostate cancer was associated with statistically significant worsening of depression scores on the PHQ-9 over 6 months compared to eugonadal controls.

Effect: adverse; 0.93; CI: 95%CI= 0.04 to 1.82

Androgen deprivation therapy in men with prostate cancer was associated with statistically significant worsening of depression scores on the PHQ-9 over 6 months compared to eugonadal controls.

Effect: adverse; 0.93; CI: 95%CI= 0.04 to 1.82

Androgen deprivation therapy in men with prostate cancer was associated with statistically significant worsening of depression scores on the PHQ-9 over 6 months compared to eugonadal controls.

Effect: adverse; 0.93; CI: 95%CI= 0.04 to 1.82

Androgen deprivation therapy in men with prostate cancer was associated with statistically significant worsening of depression scores on the PHQ-9 over 6 months compared to eugonadal controls.

Effect: adverse; 0.93; CI: 95%CI= 0.04 to 1.82

Androgen deprivation therapy in men with prostate cancer was associated with statistically significant worsening of depression scores on the PHQ-9 over 6 months compared to eugonadal controls.

Effect: adverse; 0.93; CI: 95%CI= 0.04 to 1.82

Androgen deprivation therapy in men with prostate cancer was associated with statistically significant worsening of depression scores on the PHQ-9 over 6 months compared to eugonadal controls.

Effect: adverse; 0.93; CI: 95%CI= 0.04 to 1.82

Androgen deprivation therapy in men with prostate cancer was associated with statistically significant worsening of depression scores on the PHQ-9 over 6 months compared to eugonadal controls.

Effect: adverse; 0.93; CI: 95%CI= 0.04 to 1.82

Androgen deprivation therapy in men with prostate cancer was associated with statistically significant worsening of depression scores on the PHQ-9 over 6 months compared to eugonadal controls.

Effect: adverse; 0.93; CI: 95%CI= 0.04 to 1.82

Androgen deprivation therapy in men with prostate cancer was associated with statistically significant worsening of depression scores on the PHQ-9 over 6 months compared to eugonadal controls.

Effect: adverse; 0.93; CI: 95%CI= 0.04 to 1.82

Androgen deprivation therapy in men with prostate cancer was associated with statistically significant worsening of depression scores on the PHQ-9 over 6 months compared to eugonadal controls.

Effect: adverse; 0.93; CI: 95%CI= 0.04 to 1.82

Androgen deprivation therapy in men with prostate cancer was associated with statistically significant worsening of depression scores on the PHQ-9 over 6 months compared to eugonadal controls.

Effect: adverse; 0.93; CI: 95%CI= 0.04 to 1.82

Androgen deprivation therapy in men with prostate cancer was associated with statistically significant worsening of depression scores on the PHQ-9 over 6 months compared to eugonadal controls.

Effect: adverse; 0.93; CI: 95%CI= 0.04 to 1.82

Androgen deprivation therapy in men with prostate cancer was associated with statistically significant worsening of depression scores on the PHQ-9 over 6 months compared to eugonadal controls.

Effect: adverse; 0.93; CI: 95%CI= 0.04 to 1.82

Androgen deprivation therapy in men with prostate cancer was associated with statistically significant worsening of depression scores on the PHQ-9 over 6 months compared to eugonadal controls.

Effect: adverse; 0.93; CI: 95%CI= 0.04 to 1.82

Androgen deprivation therapy in men with prostate cancer was associated with statistically significant worsening of depression scores on the PHQ-9 over 6 months compared to eugonadal controls.

Effect: adverse; 0.93; CI: 95%CI= 0.04 to 1.82

Androgen deprivation therapy in men with prostate cancer was associated with statistically significant worsening of depression scores on the PHQ-9 over 6 months compared to eugonadal controls.

Effect: adverse; 0.93; CI: 95%CI= 0.04 to 1.82

Androgen deprivation therapy in men with prostate cancer was associated with statistically significant worsening of depression scores on the PHQ-9 over 6 months compared to eugonadal controls.

Effect: adverse; 0.93; CI: 95%CI= 0.04 to 1.82

Androgen deprivation therapy in men with prostate cancer was associated with statistically significant worsening of depression scores on the PHQ-9 over 6 months compared to eugonadal controls.

Effect: adverse; 0.93; CI: 95%CI= 0.04 to 1.82

Androgen deprivation therapy in men with prostate cancer was associated with statistically significant worsening of depression scores on the PHQ-9 over 6 months compared to eugonadal controls.

Effect: adverse; 0.93; CI: 95%CI= 0.04 to 1.82